Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 11, 2009, Pages 2396-2403

  Chisaki, Ikumi ^a   Kobayashi, Masaki ^a   Itagaki, Shirou ^a   Hirano, Takeshi ^a   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ABC transporter; Liver X receptor; Regulation

Indexed keywords

25 HYDROXYCHOLESTEROL; ABC TRANSPORTER A1; BREAST CANCER RESISTANCE PROTEIN; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE;

ANIMAL EXPERIMENT; ARTICLE; BILE SECRETION; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; TRANSLATION INITIATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; HYDROCARBONS, FLUORINATED; HYDROXYCHOLESTEROLS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER NEOPLASMS; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; ORPHAN NUCLEAR RECEPTORS; P-GLYCOPROTEIN; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SULFONAMIDES; TRANSFECTION;

RATTUS;

EID: 71149110696     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.08.014     Document Type: Article

References (39)

1. Borst P., Zelcer N., and van de Wetering K. MRP2 and 3 in health and disease. Cancer Lett. 234 (2006) 51-61
2. Ho R.H., and Kim R.B. Transporters and drug therapy: implications for drug disposition and disease. Clin. Pharmacol. Ther. 78 (2005) 260-277
3. Faber K.N., Muller M., and Jansen P.L. Drug transport proteins in the liver. Adv. Drug Deliv. Rev. 55 (2003) 107-124
4. Jonker J.W., Merino G., Musters S., van Herwaarden A.E., Bolscher E., Wagenaar E., Mesman E., Dale T.C., and Schinkel A.H. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 11 (2005) 127-129
5. Zaher H., Khan A.A., Palandra J., Brayman T.G., Yu L., and Ware J.A. Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse. Mol. Pharm. 3 (2006) 55-61
6. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., Tontonoz P., Kliewer S., Willson T.M., and Edwards P.A. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277 (2002) 2908-2915
7. Greiner B., Eichelbaum M., Fritz P., Kreichgauer H.P., von Richter O., Zundler J., and Kroemer H.K. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest. 104 (1999) 147-153
8. Geick A., Eichelbaum M., and Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276 (2001) 14581-14587
9. Burk O., Arnold K.A., Geick A., Tegude H., and Eichelbaum M. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol. Chem. 386 (2005) 503-513
10. Szatmari I., Vámosi G., Brazda P., Balint B.L., Benko S., Széles L., Jeney V., Özvegy-Laczka C., Szántó A., Barta E., Balla J., Sarkadi B., and Nagy1 L. Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J. Biol. Chem. 281 (2006) 23812-23823
11. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., and Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12097-12102
12. Venkateswaran A., Repa J.J., Lobaccaro J.M., Bronson A., Mangelsdorf D.J., and Edwards P.A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275 (2000) 14700-14707
13. Costet P., Luo Y., Wang N., and Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275 (2000) 28240-28245
14. Repa J.J., Berge K.E., Pomajzl C., Richardson J.A., Hobbs H., and Mangelsdorf D.J. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β. J. Biol. Chem. 277 (2002) 18793-18800
15. Millatt L.J., Bocher V., Fruchart J.C., and Staels B. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis. Biochim. Biophys. Acta 1631 (2003) 107-118
16. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., and Tontonoz P. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 507-512
17. Kobayashi M., Chisaki I., Narumi K., Hidaka K., Kagawa T., Itagaki S., Hirano T., and Iseki K. Association between risk of myopathy and cholesterol-lowering effect: a comparison of all statins. Life Sci. 82 (2008) 969-975
18. Kobayashi M., Kagawa T., Narumi K., Itagaki S., Hirano T., and Iseki K. Bicarbonate supplementation as a preventive way in statins-induced muscle damage. J. Pharm. Pharm. Sci. 11 (2008) 1-8
19. Deryckere F., and Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. BioTechniques 16 (1994) 405
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Kobayashi M., Otsuka Y., Itagaki S., Hirano T., and Iseki K. Inhibitory effects of statins on human monocarboxylate transporter 4. Int. J. Pharm. 317 (2006) 19-25
22. Johnson B.M., Zhang P., Schuetz J.D., and Brouwer K.L. Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats. Drug Metab. Dispos. 34 (2006) 556-562
23. Kobayashi M., Fujita I., Itagaki S., Hirano T., and Iseki K. Transport mechanism for L-lactic acid in human myocytes using human prototypic embryonal rhabdomyosarcoma cell line (RD cells). Biol. Pharm. Bull. 28 (2005) 1197-1201
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
25. Sekiya M., Yahagi N., Matsuzaka T., Takeuchi Y., Nakagawa Y., Takahashi H., Okazaki H., Iizuka Y., Ohashi K., Gotoda T., Ishibashi S., Nagai R., Yamazaki T., Kadowaki T., Yamada N., Osuga J., and Shimano H. SREBP-1-independent regulation of lipogenic gene expression in adipocytes. J. Lipid Res. 48 (2007) 1581-1591
26. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., and Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Gene Dev. 9 (1995) 1033-1045
27. Miyata K.S., McCaw S.E., Patel H.V., Rachubinski R.A., and Capone J.P. The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J. Biol. Chem. 271 (1996) 9189-9192
28. Shinar D.M., Endo N., Rutledge S.J., Vogel R., Rodan G.A., and Schmidt A. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene 147 (1994) 273-276
29. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., and Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383 (1996) 728-731
30. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.-L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Wilson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 (1997) 3137-3140
31. Repa J.J., and Mangelsdorf D.J. The liver X receptor gene team: potential new players in atherosclerosis. Nat. Med. 8 (2002) 1243-1248
32. Paulusma C.C., and Oude Elferink R.P. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man. J. Mol. Med. 75 (1997) 420-428
33. Paulusma C.C., Bosma P.J., Zaman G.J., Bakker C.T., Otter M., Scheffer G.L., Scheper R.J., Borst P., and Oude Elferink R.P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271 (1996) 1126-1128
34. Büchler M., König J., Brom M., Kartenbeck J., Spring H., Horie T., and Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. Biol. Chem 271 (1996) 15091-15098
35. Kawabe T., Chen Z.S., Wada M., Uchiumi T., Ono M., Akiyama S., and Kuwano M. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2). FEBS Lett. 456 (1999) 327-331
36. Schrenk D., Baus P.R., Ermel N., Klein C., Vorderstemann B., and Kauffmann H.M. Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol. Lett. 120 (2001) 51-57
37. Evers R., Kool M., van Deemter L., Janssen H., Calafat J., Oomen L.C., Paulusma C.C., Oude Elferink R.P., Baas F., Schinkel A.H., and Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101 (1998) 1310-1319
38. Argmann C.A., Edwards J.Y., Sawyez C.G., O'Neil C.H., Hegele R.A., Pickering J.G., and Huff M.W. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J. Biol. Chem. 280 (2005) 22212-22221
39. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., Liao D., Nagy L., Edwards P.A., Curtiss L.K., Evans R.M., and Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7 (2001) 161-171